查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566973

客自訂抗體服務市場：按服務、按類型、按來源、按應用、按最終用戶：2024-2033 年全球機會分析和行業預測

Custom Antibody Services Market By Service , By Type By Source By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 233 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

自訂抗體服務市場

2023年客製自訂抗體服務市值為6億美元，預計2024年至2033年複合年成長率為8.7%，到2033年達到14億美元。

透過我們的客自訂抗體服務，我們根據使用者的要求創建抗體。抗體專為診斷、研究和治療目的而量身定做。使用自訂抗體服務的一個主要好處是能夠實現抗體對其抗原的特異性，從而獲得可靠的實驗結果。此外，對抗體進行各種修改的靈活性使得自訂抗體服務對客戶有吸引力。

用於標靶治療的個人化醫療的日益普及正在增加自訂抗體服務在醫療領域的採用。此外，製藥和生技公司加強研發活動的支出迅速增加也是市場成長的主要動力。重組技術和新型抗體趨勢預計將重新定義客自訂抗體服務市場的未來。人工智慧和機器學習演算法有望支持抗體設計和開發新一代抗體，包括單域抗體、雙特異性抗體和抗體片段。

然而，抗體生產成本高且開發時間長阻礙了客製自訂抗體服務市場的成長。此外，為抗體批准建立的品管措施和驗證流程非常嚴格且耗時。有效遵守此類標準會減緩市場成長。相較之下，由於藥物開發和研發投資的自訂，客製化抗體服務市場預計將發現一些利潤豐厚的成長機會。根據全球資料和商業智慧平台 Statista 的數據，預計 2022 年美國在藥品上的支出將達到 6,030 億美元。此外，美國製藥公司將約 21% 的收益用於研發活動。這些支出顯示自訂抗體服務市場前景光明。

按部門審查

客自訂抗體服務市場分為服務、類型、來源、應用、最終用戶和區域。依服務分類，市場分為抗體開拓、抗體生產/精製及抗體分割/標記。依類型分為單株抗體、多株抗體、重組抗體等。依來源分為小鼠、兔、其他。依應用分類，可分為腫瘤學、感染疾病、神經學、免疫學、心血管疾病等。依最終用戶分類，可分為製藥/生技公司、學術/研究機構等。從區域來看，分析包括北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

從服務來看，抗體開發領域在 2023 年佔據市場主導地位。

從類型來看，單株抗體領域是2023年市場的主要股東。

消息人士透露，2023年兔子細分市場將佔據較高佔有率。

從應用來看，2023年感染疾病細分市場佔較高佔有率。

從最終用戶來看，製藥和生技公司在 2023 年佔據了較高的市場。

按地區分類，北美地區 2023 年收益最高。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 擴大公司簡介列表
  • 歷史市場資料
  • 主要參與企業的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章客自訂抗體服務市場：依服務分類

  • 市場概況
  • 抗體開發
  • 抗體生產和精製
  • 抗體分割和標記

第5章自訂抗體服務市場：依類型

  • 市場概況
  • 單株抗體
  • 多株抗體
  • 重組抗體
  • 其他

第6章客自訂抗體服務市場：依來源分類

  • 市場概況
  • 老鼠
  • 兔子
  • 其他

第7章客自訂抗體服務市場：依應用分類

  • 市場概況
  • 腫瘤學
  • 感染疾病
  • 神經病學
  • 免疫學
  • 心血管疾病
  • 其他

第8章客自訂抗體服務市場：依最終用戶分類

  • 市場概況
  • 製藥和生物技術公司
  • 學術/研究機構
  • 其他

第9章客自訂抗體服務市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國自訂抗體服務市場
    • 加拿大客自訂抗體服務市場
    • 墨西哥客自訂抗體服務市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國客自訂抗體服務市場
    • 法國自訂抗體服務市場
    • 英國自訂抗體服務市場
    • 義大利客自訂抗體服務市場
    • 西班牙客自訂抗體服務市場
    • 其他歐洲自訂抗體服務市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本客自訂抗體服務市場
    • 中國客自訂抗體服務市場
    • 印度客自訂抗體服務市場
    • 澳洲抗體服務市場
    • 韓國自訂抗體服務市場
    • 其他亞太地區自訂抗體服務市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西客自訂抗體服務市場
    • 沙烏地阿拉伯客自訂抗體服務市場
    • 南非客自訂抗體服務市場
    • 其他拉丁美洲/中東/非洲客自訂抗體服務市場

第10章競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第11章 公司簡介

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Sino Biological, Inc.
  • Bio-Rad Laboratories, Inc
  • Kaneka Eurogentec SA
  • YenZym Antibodies, LLC.
  • OriGene Technologies, Inc.
  • Laboratory Corporation of America Holdings.
  • GenScript
簡介目錄
Product Code: A324397

Custom Antibody Services Market

The custom antibody services market was valued at $0.6 billion in 2023 and is projected to reach $1.4 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.

Custom antibody services involve producing distinguished antibodies as per user requirements. The antibodies are specifically tailored for diagnostic, research, and therapeutic purposes. A key benefit of utilizing custom antibody services is the attainability of specificity in antibodies against antigens, resulting in improved & reliable experimental results. In addition, the flexibility of integrating different modifications into the antibodies attracts clients to benefit from the custom antibody services.

Increase in the popularity of personalized medicine for targeted therapies is rising the adoption of custom antibody services in the healthcare field. In addition, with surging expenditure in the pharmaceutical and biotech sectors for the strengthening of their R&D activities, the growth of the market is being driven considerably. The future of the custom antibody services market is anticipated to be redefined by recombinant technology and novel antibody trends. AI and ML algorithm are poised to assist in the designing of antibodies and develop next-generational antibodies such as single domain antibodies, bispecific antibodies, and antibody fragments.

However, the high cost of antibody production and extended development time hamper the growth of the custom antibody services market. In addition, the quality control measures and validation processes established for the approval of antibodies are highly rigorous and time-consuming. Efficient compliance with such standards delays the growth of the market. Contrarily, with rising investments on drug development and R&D, the custom antibody services market is anticipated to witness several lucrative growth opportunities. According to Statista, a global data and business intelligence platform, the U.S. spent an estimated amount of $603 billion on medicine in 2022. Furthermore, pharma companies in the U.S. spend approximately 21% of their revenue on R&D activities. Such expenditures indicate a promising future for the custom antibody services market.

Segment Review

The custom antibody services market is segmented into service, type, source, application, end user, and region. On the basis of service, the market is divided into antibody development, antibody production & purification, and antibody fragmentation & labeling. As per type, it is classified into monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and others. Depending on source, it is categorized into mice, rabbit, and others. According to application, it is divided into oncology, infectious diseases, neurology, immunology, cardiovascular diseases, and others. By end user, it is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of service, the antibody development segment dominated the market in 2023.

As per type, the monoclonal antibodies segment was the major shareholder of the market in 2023.

Depending on source, the rabbit segment held a high share in the market in 2023.

According to application, the infectious diseases segment accounted for a high share in the market in 2023.

By end user, the pharmaceutical & biotechnology companies segment acquired a high stake in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players of the global custom antibody services market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., Sino Biological, Inc., Bio-Rad Laboratories, Inc, Kaneka Eurogentec S.A., YenZym Antibodies, LLC., OriGene Technologies, Inc., Laboratory Corporation of America Holdings., and GenScript. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Service

  • Antibody Development
  • Antibody Production and Purification
  • Antibody Fragmentation and Labeling

By Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies
  • Others

By Source

  • Mice
  • Rabbit
  • Others

By Application

  • Oncology
  • Infectious Diseases
  • Neurology
  • Immunology
  • Cardiovascular Diseases
  • Others

By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Sino Biological, Inc.
    • Bio-Rad Laboratories, Inc
    • Kaneka Eurogentec S.A.
    • YenZym Antibodies, LLC.
    • OriGene Technologies, Inc.
    • Laboratory Corporation of America Holdings.
    • GenScript

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Service
  • 4.2. Antibody Development
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Antibody Production And Purification
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Antibody Fragmentation And Labeling
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: CUSTOM ANTIBODY SERVICES MARKET, BY TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Type
  • 5.2. Monoclonal Antibodies
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Polyclonal Antibodies
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Recombinant Antibodies
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Source
  • 6.2. Mice
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Rabbit
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Application
  • 7.2. Oncology
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Infectious Diseases
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Neurology
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. Immunology
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country
  • 7.6. Cardiovascular Diseases
    • 7.6.1. Key Market Trends, Growth Factors and Opportunities
    • 7.6.2. Market Size and Forecast, By Region
    • 7.6.3. Market Share Analysis, By Country
  • 7.7. Others
    • 7.7.1. Key Market Trends, Growth Factors and Opportunities
    • 7.7.2. Market Size and Forecast, By Region
    • 7.7.3. Market Share Analysis, By Country

CHAPTER 8: CUSTOM ANTIBODY SERVICES MARKET, BY END USER

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By End User
  • 8.2. Pharmaceutical And Biotechnology Companies
    • 8.2.1. Key Market Trends, Growth Factors and Opportunities
    • 8.2.2. Market Size and Forecast, By Region
    • 8.2.3. Market Share Analysis, By Country
  • 8.3. Academic And Research Institutes
    • 8.3.1. Key Market Trends, Growth Factors and Opportunities
    • 8.3.2. Market Size and Forecast, By Region
    • 8.3.3. Market Share Analysis, By Country
  • 8.4. Others
    • 8.4.1. Key Market Trends, Growth Factors and Opportunities
    • 8.4.2. Market Size and Forecast, By Region
    • 8.4.3. Market Share Analysis, By Country

CHAPTER 9: CUSTOM ANTIBODY SERVICES MARKET, BY REGION

  • 9.1. Market Overview
    • 9.1.1 Market Size and Forecast, By Region
  • 9.2. North America
    • 9.2.1. Key Market Trends and Opportunities
    • 9.2.2. Market Size and Forecast, By Service
    • 9.2.3. Market Size and Forecast, By Type
    • 9.2.4. Market Size and Forecast, By Source
    • 9.2.5. Market Size and Forecast, By Application
    • 9.2.6. Market Size and Forecast, By End User
    • 9.2.7. Market Size and Forecast, By Country
    • 9.2.8. U.S. Custom Antibody Services Market
      • 9.2.8.1. Market Size and Forecast, By Service
      • 9.2.8.2. Market Size and Forecast, By Type
      • 9.2.8.3. Market Size and Forecast, By Source
      • 9.2.8.4. Market Size and Forecast, By Application
      • 9.2.8.5. Market Size and Forecast, By End User
    • 9.2.9. Canada Custom Antibody Services Market
      • 9.2.9.1. Market Size and Forecast, By Service
      • 9.2.9.2. Market Size and Forecast, By Type
      • 9.2.9.3. Market Size and Forecast, By Source
      • 9.2.9.4. Market Size and Forecast, By Application
      • 9.2.9.5. Market Size and Forecast, By End User
    • 9.2.10. Mexico Custom Antibody Services Market
      • 9.2.10.1. Market Size and Forecast, By Service
      • 9.2.10.2. Market Size and Forecast, By Type
      • 9.2.10.3. Market Size and Forecast, By Source
      • 9.2.10.4. Market Size and Forecast, By Application
      • 9.2.10.5. Market Size and Forecast, By End User
  • 9.3. Europe
    • 9.3.1. Key Market Trends and Opportunities
    • 9.3.2. Market Size and Forecast, By Service
    • 9.3.3. Market Size and Forecast, By Type
    • 9.3.4. Market Size and Forecast, By Source
    • 9.3.5. Market Size and Forecast, By Application
    • 9.3.6. Market Size and Forecast, By End User
    • 9.3.7. Market Size and Forecast, By Country
    • 9.3.8. Germany Custom Antibody Services Market
      • 9.3.8.1. Market Size and Forecast, By Service
      • 9.3.8.2. Market Size and Forecast, By Type
      • 9.3.8.3. Market Size and Forecast, By Source
      • 9.3.8.4. Market Size and Forecast, By Application
      • 9.3.8.5. Market Size and Forecast, By End User
    • 9.3.9. France Custom Antibody Services Market
      • 9.3.9.1. Market Size and Forecast, By Service
      • 9.3.9.2. Market Size and Forecast, By Type
      • 9.3.9.3. Market Size and Forecast, By Source
      • 9.3.9.4. Market Size and Forecast, By Application
      • 9.3.9.5. Market Size and Forecast, By End User
    • 9.3.10. UK Custom Antibody Services Market
      • 9.3.10.1. Market Size and Forecast, By Service
      • 9.3.10.2. Market Size and Forecast, By Type
      • 9.3.10.3. Market Size and Forecast, By Source
      • 9.3.10.4. Market Size and Forecast, By Application
      • 9.3.10.5. Market Size and Forecast, By End User
    • 9.3.11. Italy Custom Antibody Services Market
      • 9.3.11.1. Market Size and Forecast, By Service
      • 9.3.11.2. Market Size and Forecast, By Type
      • 9.3.11.3. Market Size and Forecast, By Source
      • 9.3.11.4. Market Size and Forecast, By Application
      • 9.3.11.5. Market Size and Forecast, By End User
    • 9.3.12. Spain Custom Antibody Services Market
      • 9.3.12.1. Market Size and Forecast, By Service
      • 9.3.12.2. Market Size and Forecast, By Type
      • 9.3.12.3. Market Size and Forecast, By Source
      • 9.3.12.4. Market Size and Forecast, By Application
      • 9.3.12.5. Market Size and Forecast, By End User
    • 9.3.13. Rest of Europe Custom Antibody Services Market
      • 9.3.13.1. Market Size and Forecast, By Service
      • 9.3.13.2. Market Size and Forecast, By Type
      • 9.3.13.3. Market Size and Forecast, By Source
      • 9.3.13.4. Market Size and Forecast, By Application
      • 9.3.13.5. Market Size and Forecast, By End User
  • 9.4. Asia-Pacific
    • 9.4.1. Key Market Trends and Opportunities
    • 9.4.2. Market Size and Forecast, By Service
    • 9.4.3. Market Size and Forecast, By Type
    • 9.4.4. Market Size and Forecast, By Source
    • 9.4.5. Market Size and Forecast, By Application
    • 9.4.6. Market Size and Forecast, By End User
    • 9.4.7. Market Size and Forecast, By Country
    • 9.4.8. Japan Custom Antibody Services Market
      • 9.4.8.1. Market Size and Forecast, By Service
      • 9.4.8.2. Market Size and Forecast, By Type
      • 9.4.8.3. Market Size and Forecast, By Source
      • 9.4.8.4. Market Size and Forecast, By Application
      • 9.4.8.5. Market Size and Forecast, By End User
    • 9.4.9. China Custom Antibody Services Market
      • 9.4.9.1. Market Size and Forecast, By Service
      • 9.4.9.2. Market Size and Forecast, By Type
      • 9.4.9.3. Market Size and Forecast, By Source
      • 9.4.9.4. Market Size and Forecast, By Application
      • 9.4.9.5. Market Size and Forecast, By End User
    • 9.4.10. India Custom Antibody Services Market
      • 9.4.10.1. Market Size and Forecast, By Service
      • 9.4.10.2. Market Size and Forecast, By Type
      • 9.4.10.3. Market Size and Forecast, By Source
      • 9.4.10.4. Market Size and Forecast, By Application
      • 9.4.10.5. Market Size and Forecast, By End User
    • 9.4.11. Australia Custom Antibody Services Market
      • 9.4.11.1. Market Size and Forecast, By Service
      • 9.4.11.2. Market Size and Forecast, By Type
      • 9.4.11.3. Market Size and Forecast, By Source
      • 9.4.11.4. Market Size and Forecast, By Application
      • 9.4.11.5. Market Size and Forecast, By End User
    • 9.4.12. South Korea Custom Antibody Services Market
      • 9.4.12.1. Market Size and Forecast, By Service
      • 9.4.12.2. Market Size and Forecast, By Type
      • 9.4.12.3. Market Size and Forecast, By Source
      • 9.4.12.4. Market Size and Forecast, By Application
      • 9.4.12.5. Market Size and Forecast, By End User
    • 9.4.13. Rest of Asia-Pacific Custom Antibody Services Market
      • 9.4.13.1. Market Size and Forecast, By Service
      • 9.4.13.2. Market Size and Forecast, By Type
      • 9.4.13.3. Market Size and Forecast, By Source
      • 9.4.13.4. Market Size and Forecast, By Application
      • 9.4.13.5. Market Size and Forecast, By End User
  • 9.5. LAMEA
    • 9.5.1. Key Market Trends and Opportunities
    • 9.5.2. Market Size and Forecast, By Service
    • 9.5.3. Market Size and Forecast, By Type
    • 9.5.4. Market Size and Forecast, By Source
    • 9.5.5. Market Size and Forecast, By Application
    • 9.5.6. Market Size and Forecast, By End User
    • 9.5.7. Market Size and Forecast, By Country
    • 9.5.8. Brazil Custom Antibody Services Market
      • 9.5.8.1. Market Size and Forecast, By Service
      • 9.5.8.2. Market Size and Forecast, By Type
      • 9.5.8.3. Market Size and Forecast, By Source
      • 9.5.8.4. Market Size and Forecast, By Application
      • 9.5.8.5. Market Size and Forecast, By End User
    • 9.5.9. Saudi Arabia Custom Antibody Services Market
      • 9.5.9.1. Market Size and Forecast, By Service
      • 9.5.9.2. Market Size and Forecast, By Type
      • 9.5.9.3. Market Size and Forecast, By Source
      • 9.5.9.4. Market Size and Forecast, By Application
      • 9.5.9.5. Market Size and Forecast, By End User
    • 9.5.10. South Africa Custom Antibody Services Market
      • 9.5.10.1. Market Size and Forecast, By Service
      • 9.5.10.2. Market Size and Forecast, By Type
      • 9.5.10.3. Market Size and Forecast, By Source
      • 9.5.10.4. Market Size and Forecast, By Application
      • 9.5.10.5. Market Size and Forecast, By End User
    • 9.5.11. Rest of LAMEA Custom Antibody Services Market
      • 9.5.11.1. Market Size and Forecast, By Service
      • 9.5.11.2. Market Size and Forecast, By Type
      • 9.5.11.3. Market Size and Forecast, By Source
      • 9.5.11.4. Market Size and Forecast, By Application
      • 9.5.11.5. Market Size and Forecast, By End User

CHAPTER 10: COMPETITIVE LANDSCAPE

  • 10.1. Introduction
  • 10.2. Top Winning Strategies
  • 10.3. Product Mapping of Top 10 Player
  • 10.4. Competitive Dashboard
  • 10.5. Competitive Heatmap
  • 10.6. Top Player Positioning, 2023

CHAPTER 11: COMPANY PROFILES

  • 11.1. Thermo Fisher Scientific Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Key Executives
    • 11.1.3. Company Snapshot
    • 11.1.4. Operating Business Segments
    • 11.1.5. Product Portfolio
    • 11.1.6. Business Performance
    • 11.1.7. Key Strategic Moves and Developments
  • 11.2. Merck KGaA
    • 11.2.1. Company Overview
    • 11.2.2. Key Executives
    • 11.2.3. Company Snapshot
    • 11.2.4. Operating Business Segments
    • 11.2.5. Product Portfolio
    • 11.2.6. Business Performance
    • 11.2.7. Key Strategic Moves and Developments
  • 11.3. Agilent Technologies, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Key Executives
    • 11.3.3. Company Snapshot
    • 11.3.4. Operating Business Segments
    • 11.3.5. Product Portfolio
    • 11.3.6. Business Performance
    • 11.3.7. Key Strategic Moves and Developments
  • 11.4. Sino Biological, Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Key Executives
    • 11.4.3. Company Snapshot
    • 11.4.4. Operating Business Segments
    • 11.4.5. Product Portfolio
    • 11.4.6. Business Performance
    • 11.4.7. Key Strategic Moves and Developments
  • 11.5. Bio-Rad Laboratories, Inc
    • 11.5.1. Company Overview
    • 11.5.2. Key Executives
    • 11.5.3. Company Snapshot
    • 11.5.4. Operating Business Segments
    • 11.5.5. Product Portfolio
    • 11.5.6. Business Performance
    • 11.5.7. Key Strategic Moves and Developments
  • 11.6. Kaneka Eurogentec S.A.
    • 11.6.1. Company Overview
    • 11.6.2. Key Executives
    • 11.6.3. Company Snapshot
    • 11.6.4. Operating Business Segments
    • 11.6.5. Product Portfolio
    • 11.6.6. Business Performance
    • 11.6.7. Key Strategic Moves and Developments
  • 11.7. YenZym Antibodies, LLC.
    • 11.7.1. Company Overview
    • 11.7.2. Key Executives
    • 11.7.3. Company Snapshot
    • 11.7.4. Operating Business Segments
    • 11.7.5. Product Portfolio
    • 11.7.6. Business Performance
    • 11.7.7. Key Strategic Moves and Developments
  • 11.8. OriGene Technologies, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Key Executives
    • 11.8.3. Company Snapshot
    • 11.8.4. Operating Business Segments
    • 11.8.5. Product Portfolio
    • 11.8.6. Business Performance
    • 11.8.7. Key Strategic Moves and Developments
  • 11.9. Laboratory Corporation of America Holdings.
    • 11.9.1. Company Overview
    • 11.9.2. Key Executives
    • 11.9.3. Company Snapshot
    • 11.9.4. Operating Business Segments
    • 11.9.5. Product Portfolio
    • 11.9.6. Business Performance
    • 11.9.7. Key Strategic Moves and Developments
  • 11.10. GenScript
    • 11.10.1. Company Overview
    • 11.10.2. Key Executives
    • 11.10.3. Company Snapshot
    • 11.10.4. Operating Business Segments
    • 11.10.5. Product Portfolio
    • 11.10.6. Business Performance
    • 11.10.7. Key Strategic Moves and Developments